Closed tender

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE

Details

Value
GBP 1,520
Topic
Pharmaceutical products
Published
27 April 2021
Submission
26 May 2021

Tender description

NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE: Offer reference number: CM/PHG/21/5639/00 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months) FIND A TENDER (FTS) Reference number: 2021/S 000-008845 Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.

Timeline

  1. Completed: Tender published27 April 2021
    Current notice
  2. Completed: Submission date26 May 2021

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed LSNE.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.